Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility Considerations for Gender-Diverse People.

Obstetrics and gynecology clinics of North America·2026
Same author

Aspirin enhances endometrial decidualization markers in vitro among women with and without endometriosis.

Reproduction & fertility·2026
Same author

Association of <i>in vitro</i> fertilization with cesarean delivery in nulliparous, term, singleton, vertex pregnancies.

Journal of perinatal medicine·2025
Same author

Medical crowdfunding for cancer patients seeking fertility treatments: a cross-sectional analysis.

F&S reports·2025
Same author

Association of in vitro fertilization with severe maternal morbidity in low-risk patients without comorbidities.

Fertility and sterility·2024
Same author

Characteristics of patients seeking fertility care in a low-income setting.

JBRA assisted reproduction·2024
Same journal

Fresh vs. frozen donor oocytes: which strategy best serves patients in contemporary assisted reproductive technology?

Fertility and sterility·2026
Same journal

From fetal life to adulthood: cardiometabolic health of offspring conceived by assisted reproductive technologies, a systematic review.

Fertility and sterility·2026
Same journal

Uterus-Sparing Laparoscopic Reversal of Complete Non-Puerperal uterine Inversion: A rare Case and Challenging Procedure!

Fertility and sterility·2026
Same journal

Minimally Invasive, Fertility-Sparing Surgical Management of Multiple Bilateral Ovarian Dermoid Cysts.

Fertility and sterility·2026
Same journal

Preconception dietary patterns in association with live birth and pregnancy loss: a couples-based approach.

Fertility and sterility·2026
Same journal

Corrigendum to "Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion" [Fertil Steril 2023;120:973-82].

Fertility and sterility·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

Views and Reviews: Therapeutic Donor Insemination.

Cory B French1, Randi H Goldman1

  • 1Northwell Health Fertility, Northwell Health, 300 Community Drive, Manhasset, NY; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY.

Fertility and Sterility
|June 10, 2026
PubMed
Summary
This summary is machine-generated.

Therapeutic donor insemination (TDI) offers viable family-building options. For younger patients, TDI success rates are comparable to natural conception, but older patients should consider in vitro fertilization (IVF) sooner.

More Related Videos

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Related Experiment Videos

Last Updated: Jun 12, 2026

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Area of Science:

  • Reproductive Medicine
  • Human Reproduction
  • Infertility Management

Background:

  • Therapeutic donor insemination (TDI) is a key method for individuals and couples needing donor gametes.
  • Clinical management of TDI involves optimizing live birth rates and cost-effectiveness.
  • Decisions regarding transitioning to in vitro fertilization (IVF) are crucial.

Purpose of the Study:

  • To review clinical considerations in therapeutic donor insemination (TDI).
  • To focus on live birth rate estimation, cost-effectiveness, and timing for transition to in vitro fertilization (IVF).

Main Methods:

  • Review of clinical considerations in TDI management.
  • Analysis of live birth rates based on age and cycle number.
  • Evaluation of cost-effectiveness strategies and IVF transition criteria.

Main Results:

  • Natural cycle TDI live birth rates approximate natural conception (18-20% per cycle <37 years; <5-10% ≥40 years).
  • Cumulative rates for six cycles are 50-60% (<37 years) and <10-15% (≥40 years), diminishing significantly after age 42.
  • Empiric ovulation induction offers minimal benefit in younger ovulatory patients and increases multiple gestation risk; it should be case-by-case.
  • Cost-effectiveness is improved by avoiding unnecessary ovulation induction, using home LH monitoring, single insemination, and minimizing unproven therapies.
  • For younger patients (<35 years), three natural TDI cycles (50-60% cumulative) may approximate one IVF cycle (40-50%).
  • For older patients (≥40 years), earlier transition to IVF is recommended due to diminishing returns.

Conclusions:

  • Therapeutic donor insemination (TDI) success is age-dependent, with rates declining significantly after age 42.
  • Cost-effective TDI management involves strategic ovulation induction and avoiding unproven therapies.
  • Individualized decision-making, considering patient age, preference, and treatment fatigue, is essential for transitioning to in vitro fertilization (IVF).